Development
Cullinan Therapeutics, Inc.
CGEM
$7.88
-$0.20-2.48%
NASDAQ
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -0.05% | -19.02% | -19.51% | 24.09% | 60.88% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 82.79% | 67.90% | -45.66% | 11.71% | 17.74% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.21% | -18.10% | -20.01% | 23.80% | 59.99% |
|
|||||
Total Current Assets | 1.21% | -18.10% | -20.01% | 23.80% | 59.99% |
Net Property, Plant & Equipment | -33.41% | -24.53% | 313.77% | 302.07% | 6,788.31% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -0.22% | 359.00% | -97.67% | 212.24% |
Total Assets | -13.71% | -19.85% | -21.77% | 17.72% | 28.35% |
|
|||||
Total Accounts Payable | -6.28% | -37.27% | -19.55% | -67.79% | -16.06% |
Total Accrued Expenses | 94.05% | 62.12% | 17.11% | 18.61% | 57.84% |
Short-term Debt | -- | -- | -- | 129.98% | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.34% | 122.27% | 209.94% | 199.42% | -- |
Total Finance Division Other Current Liabilities | -85.35% | -88.84% | -97.84% | -- | 541.01% |
Total Other Current Liabilities | -85.35% | -88.84% | -97.84% | -- | 541.01% |
Total Current Liabilities | 25.06% | -13.55% | -68.28% | 51.65% | 91.54% |
|
|||||
Total Current Liabilities | 25.06% | -13.55% | -68.28% | 51.65% | 91.54% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | 129.98% | -- |
Capital Leases | -40.11% | -38.73% | 358.72% | 330.71% | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 16.10% | -16.78% | -64.22% | 63.07% | 120.88% |
|
|||||
Common Stock & APIC | 11.85% | 5.88% | 5.76% | -0.05% | 0.10% |
Retained Earnings | -321.13% | -746.62% | -3,643.33% | 38.21% | 69.99% |
Treasury Stock & Other | 95.04% | 73.25% | 55.27% | 60.37% | -210.38% |
Total Common Equity | -15.20% | -20.01% | -17.36% | 15.99% | 25.90% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -15.20% | -20.01% | -17.36% | 15.99% | 25.90% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -15.16% | -20.01% | -17.37% | 15.78% | 25.78% |
|